tiprankstipranks
Advertisement
Advertisement

HK:9926 Stock Latest News

Akeso: Robust FY25 Execution and Late‑Stage Oncology Pipeline Drive Upside and Higher Target Price
RatingsAkeso: Robust FY25 Execution and Late‑Stage Oncology Pipeline Drive Upside and Higher Target Price
7d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
10d ago
RADX
SMMT
Summit Therapeutics to present multiple ivonescimab data sets at ELCC 2026
PremiumThe Fly
Summit Therapeutics to present multiple ivonescimab data sets at ELCC 2026
10d ago
SMMT
Akeso Boosts Revenue and R&D While Trimming Adjusted EBITDA Loss in 2025
PremiumCompany Announcements
Akeso Boosts Revenue and R&D While Trimming Adjusted EBITDA Loss in 2025
11d ago
Akeso Advances Dual-Antibody Cancer Trial, Keeping Oncology Pipeline in Focus
PremiumCompany Announcements
Akeso Advances Dual-Antibody Cancer Trial, Keeping Oncology Pipeline in Focus
19d ago
9926
Akeso’s AK120 Phase II Completion Adds New Momentum to Its Atopic Dermatitis Pipeline
PremiumCompany AnnouncementsAkeso’s AK120 Phase II Completion Adds New Momentum to Its Atopic Dermatitis Pipeline
20d ago
9926
Akeso Schedules Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Akeso Schedules Board Meeting to Approve 2025 Annual Results
21d ago
Akeso Advances AK112 Trial in Liver Cancer, Setting Up a New Catalyst for HK:9926
Premium
Company Announcements
Akeso Advances AK112 Trial in Liver Cancer, Setting Up a New Catalyst for HK:9926
1M ago
9926
Akeso Completes Key Early-Stage Cancer Trial, Keeping Investor Focus on Pipeline Upside
PremiumCompany Announcements
Akeso Completes Key Early-Stage Cancer Trial, Keeping Investor Focus on Pipeline Upside
1M ago
9926
Akeso’s AK112 Lung Cancer Trial Reaches Completion: What Investors Should Watch Next
PremiumCompany Announcements
Akeso’s AK112 Lung Cancer Trial Reaches Completion: What Investors Should Watch Next
1M ago
9926
Akeso Moves AK139 Into Phase II, Targeting Growth in Seasonal Allergy Market
PremiumCompany Announcements
Akeso Moves AK139 Into Phase II, Targeting Growth in Seasonal Allergy Market
1M ago
9926
Akeso Advances New Asthma Biologic AK139 Into Phase II, Extending Its Respiratory Pipeline
PremiumCompany Announcements
Akeso Advances New Asthma Biologic AK139 Into Phase II, Extending Its Respiratory Pipeline
1M ago
9926
Akeso Advances AK104 Into Phase 3 Colon Cancer Trial, Signaling Long-Term Growth Potential
PremiumCompany AnnouncementsAkeso Advances AK104 Into Phase 3 Colon Cancer Trial, Signaling Long-Term Growth Potential
1M ago
9926
Akeso Grants JumpCan Exclusive Mainland China Rights to Cholesterol Drug 伊喜寧®
Premium
Company Announcements
Akeso Grants JumpCan Exclusive Mainland China Rights to Cholesterol Drug 伊喜寧®
2M ago
Akeso Details Long-Term MAb Contract Manufacturing and Demand Assumptions
Premium
Company Announcements
Akeso Details Long-Term MAb Contract Manufacturing and Demand Assumptions
2M ago
Akeso announces NMPA acceptance of second NDA for gumokimab
PremiumThe Fly
Akeso announces NMPA acceptance of second NDA for gumokimab
3M ago
Akeso downgraded to Hold from Buy at Daiwa
PremiumThe Fly
Akeso downgraded to Hold from Buy at Daiwa
3M ago
Akeso Restructures MAb Manufacturing Deal as Joint Venture Becomes Connected Transaction
PremiumCompany Announcements
Akeso Restructures MAb Manufacturing Deal as Joint Venture Becomes Connected Transaction
3M ago
Akeso’s Innovative Drugs Included in China’s 2025 NRDL
PremiumCompany Announcements
Akeso’s Innovative Drugs Included in China’s 2025 NRDL
4M ago
Akeso, Inc. Advances Cancer Treatment with New Phase I Study on AK137
PremiumCompany AnnouncementsAkeso, Inc. Advances Cancer Treatment with New Phase I Study on AK137
5M ago
9926
Akeso, Inc. Launches Promising Phase II Study for NSCLC Treatment
Premium
Company Announcements
Akeso, Inc. Launches Promising Phase II Study for NSCLC Treatment
5M ago
9926
Akeso, Inc. Advances Cancer Treatment with Promising AK146D1 Study
Premium
Company Announcements
Akeso, Inc. Advances Cancer Treatment with Promising AK146D1 Study
5M ago
9926

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >